Heparin-Associated Thrombocytopenia Treatment with Low Molecular Weight Heparin
- 1 January 1986
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 55 (01), 037-039
- https://doi.org/10.1055/s-0038-1661442
Abstract
Eight patients with heparin associated thrombocytopenia (HAT) were treated by a low molecular weight heparin derivative (LMW). Biological and clinical improvement occurred in all patients. This efficiency confirms the antithrombotic activity of LMW and allows its use in patients with HAT.Keywords
This publication has 13 references indexed in Scilit:
- Heparin-Associated ThrombocytopeniaAnnals of Internal Medicine, 1984
- Heparin and ThrombocytopeniaAnnals of Internal Medicine, 1984
- Thrombocytopenia and Heparin-Associated ThrombosisAnnals of Internal Medicine, 1984
- HEPARIN INDUCED THROMBOCYTOPAENIA - DIAGNOSIS AND COMPLICATIONS1980
- HEPARIN-INDUCED THROMBOCYTOPENIA, THROMBOSIS, AND HEMORRHAGE1979
- Subcutaneous heparin-induced thrombocytopeniaArchives of Internal Medicine, 1978
- Heparin-induced thrombocytopeniaArchives of Internal Medicine, 1978
- Arterial thromboembolism in patients receiving systemic heparin therapyJournal of Bone and Joint Surgery, 1977
- Heparin Induced ThrombocytopeniaAnnals of Surgery, 1977
- Heparin-Induced Immune ThrombocytopeniaNew England Journal of Medicine, 1976